Iteos Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Good morning, everyone. My name is Daina Graybosch. I'm the immuno-oncology analyst here at SVB Securities. And I'm excited to have the management team from iTeos Therapeutics for a fireside chat. I'm going to hand it over to Michel, who's going to walk through a few introductory slides, everybody, starting with the same context on the pipeline, and then we'll move into the Q&A. (Conference Instructions)
And with that, I'll turn it over to Michel.
Thank you, Daina, and thank you to SVB for the opportunity to present iTeos's story today. Good morning to everybody listening to the presentation today on the webcast. When I founded iTeos my mission, then and now, has been to build a company that would master human immunology to save the most relevant targets and [give a better sense]. And we are going to show you what we have learned since -- from the [biology].
During this presentation, we make forward-looking statements. Let's start
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |